Donnerstag, 19. Juli 2018


  • Pressemitteilung BoxID 425997

Together Against Stroke

Cooperation between Philips and apoplex medical provides substantial improvement in stroke care

Hamburg / Pirmasens, (lifePR) - By automated merging of patient information, apoplex medical technologies and Philips will take the next step in the battle against stroke. Particularly stroke patients with strokes of unknown origin could benefit from this.

Undetected atrial fibrillation is considered to be a potential cause for stroke. Several methods for the detection of paroxysmal atrial fibrillation can help to confirm this assumption. With the fully automated ECG analysis for the detection of atrial fibrillation SRAclinic (SRA = Stroke Risk Analysis), developed by apoplex medical technologies, a method is now available, which is significantly superior to all previous standard methods.[1]The ECG data for this analysis are provided for example by the patient monitoring system Philips IntelliVue. It records the patient data at the stroke unit and exports them pseudonymized at the touch of a button to the analysis server in the data center of apoplex medical technologies. There the data are analysed for paroxysmal atrial fibrillation (pxVHF) and summarized for the physician in a clearly arranged and expressive report. Based on this, a therapy with anticoagulants can be initiated, which reduces the risk for further strokes substantially.

"A retrospective output function, integrated in the Philips IntelliVue Monitoring System, enables the transfer of up to 96 hours long term ECGs without additional interface effort", explains Thomas Groß, Business Manager Patient Monitoring at Philips Healthcare Germany. This simplifies the clinical processes in a considerable extent. All stroke patients connected to a Philips Monitoring System are examined for atrial fibrillation during their complete bed time. There are no additional activities, neither for the physicians nor for the nursing staff, which could lead to further burden. As the data center of apoplex medical technologies is available to all hospitals, there are no additional technical requirements at the hospitals.

For Albert Hirtz, General Manager at apoplex medical technologies, it is obvious that patients and the health system equally benefit from such prevention: "each prevented stroke is a piece of luck for the people. And for the society it means a substantial reduction of costs in the end." In Germany 250.000 people suffer from stroke each year. In 35 to 40 percent of these strokes, the origin is not detectable.

Further information to SRAclinic at: www.apoplexmedical.com Further information to IntelliVue Patient Monitoring at: www.philips.de

About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

About apoplex medical technologies

apoplex medical technologies GmbH was founded in 2004 in Pirmasens, in the west of the Rhineland-Palatinate, and, within the field of medical technology, specializes in new and innovative technological products for the prevention of strokes throughout the world. The subsidiary of Geratherm Medical AG focuses on easily applicable and efficient methods of patient screening using medical-technical applications to prevent strokes and vascular dementia. The SRA (Stroke Risk Analysis) procedure is the first practicable screening method for paroxysmal atrial fibrillation. It is available in versions for use in medical practices and stroke units. apoplex medical technologies is supported by an extensive academic and clinical network, which professionally supplements its own core competences in the fields of mathematics, physics and medicine. Further information is available at www.apoplexmedical.com.

[1] Rizos et al. (Stroke, 2012,43:2689-2694): Continuous Stroke Unit Electrocardiographic Monitoring Versus 24-Hour Holter Electrocardiography for Detection of Paroxysmal Atrial Fibrillation After Stroke. Universitätsklinikum Heidelberg

Diese Pressemitteilungen könnten Sie auch interessieren

ICE AESTHETIC enters the UK – Medizinische Kryolipolyse in London

, Gesundheit & Medizin, ICE AESTHETIC GmbH

Nicht nur in Deutschland erfreut sich die innovative Behandlungsmethode der Kryolipolyse wachsender Beliebtheit. Im Vereinigten Königreich ist...

Kinder-Orthopädie: Kinder sind KEINE kleinen Erwachsenen

, Gesundheit & Medizin, NewsWork AG

Wenn Erwachsene zum Orthopäden gehen, sind meist Schmerzen, Gelenk- oder Rückenprobleme die Ursache. Kommen Kinder zum Orthopäden sind die Auslöser...

Allogene Stammzelltransplantation bei bestimmten Lymphomen: Nutzen unklar

, Gesundheit & Medizin, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen - IQWiG

Das Non-Hodgkin-Lymphom ist eine bestimmte Form von Lymphdrüsenkrebs, also eine Erkrankung des blutbildenden Systems. Sie tritt selten auf und...

Disclaimer